PRC2 primes bivalent genes for transcription induction independent of histone methyltransferase activity
Science China Life Sciences · 2024
DOI: 10.1007/s11427-024-2573-2 ↗Kurz gefasst
Leserbrief in der Zeitschrift Science China Life Sciences, 2024. Verfasst von Meihan Gong und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Experimental Hematology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key …. Hauptthemen laut MEDLINE: Polycomb Repressive Complex 2, Histone Methyltransferases. Die Arbeit nennt 14 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Experimental Hematology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Educati…
- Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Liangzhu Laboratory, Institute of Hematology, Zhejiang University, Hangzhou, 311113, China.
Zitieren
APA
Gong, M., Yuan, Y., Dai, Z., Lv, X., Su, J., Huo, D., Niu, L., Chen, X., & Wu, X. (2024). PRC2 primes bivalent genes for transcription induction independent of histone methyltransferase activity. Science China Life Sciences. https://doi.org/10.1007/s11427-024-2573-2
Vancouver
Gong M, Yuan Y, Dai Z, Lv X, Su J, Huo D, et al. PRC2 primes bivalent genes for transcription induction independent of histone methyltransferase activity. Science China Life Sciences. 2024. doi:10.1007/s11427-024-2573-2
BibTeX
@article{Gong2024,
author = {Gong, Meihan and Yuan, Ye and Dai, Zhongye and Lv, Xuejiao and Su, Jiacheng and Huo, Dawei and Niu, Lin and Chen, Xu and Wu, Xudong},
title = {PRC2 primes bivalent genes for transcription induction independent of histone methyltransferase activity},
journal = {Science China Life Sciences},
year = {2024},
doi = {10.1007/s11427-024-2573-2}
}
EUVIMED